nivolumabsunitinibpembrolizumabaxitinib
…rolled in a first-line phase II trial of the anti-PD-1 antibody nivolumab.13 Together, these data suggest then an immunologically enriche…
1articles mentioning drugs
2drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: JAVELIN101 Angio10 ×
JAVELIN101 Angio10
This drug is selected. Its supporting articles are shown below.